NATURAL HEALTH TRENDS CORP
NATURAL HEALTH TRENDS CORP Q3 FY2024 earnings call
October 30, 2024 · fiscal period ended 2024-09
EPS · actual vs est
Revenue · actual vs est
Summary
Generated 2024-10-30
Management highlights
- Revenue was $10.7 million, a 1% increase compared to Q3 2023, though growth pace isn't ideal due to consumer hesitancy.
- Customers and leaders engaged; company adapting by adjusting programs.
- In China/Hong Kong, teams did in-person meetings, trainings, charity, and incentive trip to Turkey; Q4 to roll out new products like Skindulgence serum, collagen supreme, Root Revive.
- Global staff hosting meetings, training, recognition events; Colombia market opened October 1.
- Incentive trips to Peru, Paris; digital enhancement project to roll out early next year to boost productivity.
Segment performance
Total revenue for the third quarter was $10.7 million, a 1% increase compared to $10.6 million in the third quarter of 2023. Gross profit margin declined to 74.1% from 74.7% in the third quarter of last year due to higher costs related to the Premium Noni Juice product. Commissions expense as a percent of total revenue for the third quarter was 40.5% compared to 41.1% a year ago. Selling, general and administrative expenses for the quarter were $3.9 million, flat compared to a year ago. Operating loss for the quarter was $275,000 compared to $292,000 in the third quarter last year. Net income for the third quarter was $35,000 or breakeven per diluted share compared to $172,000 or $0.02 per diluted share in the third quarter of 2023. Net cash used in operating activities was $3.5 million during the first 9 months of 2024 compared to $4.2 million during the comparable period a year ago. Total cash, cash equivalents and marketable securities was $46.3 million at September 30, down from $48.7 million at June 30 due to the quarterly dividend payment.
Guidance
- Ambitious activity calendar continues in Q4 with new product rollouts in China/Hong Kong.
- Anticipate rolling out digital enhancement project to members and customers early next year.
- Board declared quarterly cash dividend of $0.20 per share, payable November 22.
Risks
- Consumer hesitancy in main market affecting business.
- Uncertainty in evolving business landscape impacting performance.
Key numbers
Reported versus consensus
Earnings calendar feed
| Metric | Reported | Consensus | Delta | Prior year |
|---|---|---|---|---|
| EPS | $0.00 | — | — | $0.02 |
| Revenue | $10.7M | — | — | $10.6M |
Transcript
October 30, 2024Full transcript unavailable for redistribution
The structured summary above covers the available call sections. Full transcript text is not included on this page.
Continue exploring
Prior quarters
This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.